International Conference on HIV and Drug Development Research
ICHDDR
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the latest advancements in the development of antiretroviral therapies for HIV. Researchers will present novel compounds and therapeutic strategies aimed at improving treatment outcomes.
SDG 3
SDG 4
This session will explore the design and execution of clinical trials in HIV research, emphasizing innovative methodologies and their impact on patient outcomes. Attendees will gain insights into best practices for trial management and data interpretation.
SDG 3
SDG 9
This track will address cutting-edge molecular diagnostic techniques for the detection and monitoring of HIV. Discussions will highlight the role of these technologies in enhancing patient care and guiding treatment decisions.
SDG 3
SDG 4
Focusing on the bridge between laboratory research and clinical application, this session will showcase translational studies that have led to significant advancements in HIV treatment. Participants will discuss challenges and successes in moving research from bench to bedside.
SDG 3
SDG 9
This track will highlight innovative therapeutic approaches that enhance patient care for those living with HIV. Presentations will cover personalized medicine, adherence strategies, and the integration of new therapies into existing treatment regimens.
SDG 3
SDG 10
This session will delve into the laboratory techniques that underpin HIV research, including cell culture, viral load measurement, and resistance testing. Participants will discuss the importance of these techniques in advancing our understanding of HIV pathogenesis.
SDG 3
SDG 9
This track will examine effective public health strategies aimed at reducing HIV transmission rates. Presentations will focus on community-based interventions, education programs, and policy initiatives that have demonstrated success.
SDG 3
SDG 6
This session will explore the role of community programs in providing comprehensive care for individuals living with HIV. Discussions will highlight successful models of care that integrate social support, education, and medical treatment.
SDG 3
SDG 10
This track will provide a global overview of HIV drug development efforts, highlighting disparities and challenges faced in different regions. Researchers will share insights on collaborative initiatives and international partnerships.
SDG 3
SDG 17
This session will address the ethical challenges associated with conducting research in HIV, including informed consent, data privacy, and the implications of trial results. Participants will engage in discussions about maintaining ethical standards in clinical practice.
SDG 3
SDG 16
This track will focus on emerging trends and future directions in HIV research, including potential breakthroughs in vaccine development and gene therapy. Experts will discuss the implications of these advancements for public health and patient care.
SDG 3
SDG 9